Skip to the main content

Smilestone Asset Management

Founded 2007 Website
Cheque Size$1M to $50M
Stages10
Industries15
Markets20
Stated Portfolio4
Operating Since2007 (19y)

About Smilestone Asset Management

Smilestone Asset Management is a Chinese private equity firm headquartered in Shanghai, specializing in investments across multiple sectors, including healthcare, technology, and consumer goods. The firm employs a long/short equity strategy and focuses on fundamental, sector-oriented investment approaches that emphasize both value and growth styles. In addition to its hedge fund activities, Smilestone engages in private equity, growth, and PIPE investments, primarily targeting sectors such as consumer goods, advanced manufacturing, and medicine. The firm's investment strategy is characterized by a disciplined approach, targeting companies at various stages of development, from seed to late-stage investments, including buyouts and distressed assets. Smilestone's portfolio spans a diverse range of industries, reflecting its commitment to identifying and nurturing high-potential companies across different sectors. The firm's focus on both value and growth investment styles allows it to adapt to various market conditions and opportunities. Smilestone Asset Management has a track record of successful investments, with a portfolio that includes companies in healthcare, technology, and consumer goods sectors. The firm's disciplined investment approach and focus on fundamental analysis have contributed to its reputation in the private equity landscape. Smilestone continues to seek opportunities to invest in high-potential companies, leveraging its expertise and network to drive value creation for its stakeholders.

Geographical Focus

African markets1

Other stated markets19

United StatesUnited KingdomCanadaGermanyHong KongJapanAustraliaSingaporeChinaIndiaBrazilFranceUnited Arab EmiratesMexicoSouth KoreaSaudi ArabiaRussiaSouth East AsiaTaiwan

Requirements

Strong management team, Scalable business model, Competitive market position, Clear exit strategy, Alignment with Smilestone's investment philosophy

Stated Portfolio4

AriBio
Yuyuan Technology
ImmuneOnco Biopharma
Cosemitech

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.